The growing demand for high-purity amino acids in food, pharmaceutical, and cosmetic industries highlights the need for precise crystallization control. Particle size formed during crystallization strongly influences downstream processing and product ...
The growing demand for high-purity amino acids in food, pharmaceutical, and cosmetic industries highlights the need for precise crystallization control. Particle size formed during crystallization strongly influences downstream processing and product quality, making reliable kinetic estimation essential. However, neutral amino acids form very small initial crystals (10–50 µm), making nucleation difficult to detect, and conventional tools such as FBRM often misclassify fine crystals. To overcome these challenges, a droplet-based evaporative system, originally developed for protein crystallization, is introduced to study L-tryptophan.
Unlike conventional methods, a novel projected area-based kinetic model (Ac) was developed to quantify the complex dendritic growth of L-tryptophan, moving beyond the limitations of standard polyhedral models. Crystallization proceeds within a single suspended droplet under controlled evaporation, minimizing external disturbances and sample consumption (5 µL). Crucially, an automated cyclic protocol with an intensified rehydration step (RH 98%) was established to eliminate the 'kinetic memory effect,' ensuring the acquisition of reliable stochastic nucleation data. This approach offers a practical, high-throughput method to estimate intrinsic kinetic parameters and guide optimal crystallization conditions.